Search the Archive

AIDS #303996

CBS Evening News for Monday, May 06, 1985
View other clips in this broadcast →

Material supplied by VTNA may be used for educational analysis or research only. Any editing, reproduction, publication, rebroadcast, public showing or public display may be prohibited by copyright laws.

(Studio) No. reported cases of acquired immune deficiency syndrome (AIDS) and AIDS-related deaths in United States noted.
REPORTER: Dan Rather

(San Francisco, California) Incr. use of unapproved experimental drug isoprinosine, available in Mexico, by AIDS victims examined; films shown. [Dr. Don. ABRAMS - attributes usage to desperation.] Status of government testing of isoprinosine on homosexuals with signs of early AIDS outlined. [Dr. Miguel ROMERO - claims drug helps.] Side effects listed. [San Francisco AID Fndn. spokesperson Chuck FRUTCHEY - opposes victims using drug.]
REPORTER: Terry Drinkwater

Drinkwater, Terry;
Rather, Dan

Note to sponsor members: The Vanderbilt Television News Archive video player requires a modern operating system and browser to work properly. If you are experiencing playback problems, check the minimum requirements and adjust your setup accordingly. After adjustments, if you continue to experience problems, please contact us.

Welcome! Above is the abstract of the item that you're interested in viewing from the Vanderbilt Television News Archive's collection. You have three options if you'd like to view this item:

  • You may request a loan of this video by registering on our website and placing an order.
  • You may visit the Television News Archive on the Vanderbilt campus to view on-site from the Archive's collection.
  • If you are associated with a college or university, you may ask your library if they would like to become a sponsor, which would give students and faculty at your institution the ability to view items from our collection.

If you believe that you are associated with a sponsoring college or university and have received this message in error, please let us know.